Syngene International Limited — Others, 01-04-2025: Appointment

Syngene International Limited has announced a board meeting regarding the appointment of Mr. Peter Bains as an Additional Director and the Managing Director & Chief Executive Officer, effective from April 1, 2025, pending shareholder approval. Mr. Bains brings over 30 years of strategic and operational leadership experience in the biopharmaceutical sector, having previously served as CEO of Syngene and held significant positions at GlaxoSmithKline and Sosei Group. This leadership change could enhance investor sentiment, given Mr. Bains' extensive background and the potential for strengthened governance and strategic direction for the company.